Neoadjuvant Immunotherapy: An Evolving Paradigm Shift?
J Natl Cancer Inst
.
2021 Jul 1;113(7):799-800.
doi: 10.1093/jnci/djaa217.
Authors
Marijo Bilusic
1
,
James L Gulley
1
Affiliation
1
Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
PMID:
33432346
PMCID:
PMC8246798
DOI:
10.1093/jnci/djaa217
No abstract available
MeSH terms
Humans
Immunologic Factors
Immunotherapy*
Neoadjuvant Therapy*
Substances
Immunologic Factors